A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants
Clinical trial NCT07528053 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07528053
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-28
- Primary completion
- 2026-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.